Improving South African Government Workers' Capacities to Deliver HIV Interventions

Sponsor
University of California, Los Angeles (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02957799
Collaborator
National Institute of Mental Health (NIMH) (NIH), University of Stellenbosch (Other)
840
2
2
76
420
5.5

Study Details

Study Description

Brief Summary

The purpose of this study is to address the United States Office of AIDS Research highest priorities: improving the workforce, reducing health disparities, and addressing HIV comorbidities. UCLA will randomize the government-funded community health workers (CHW) from 16 clinics in matched rural areas in the Eastern Cape in South Africa to either: 1) the Accountable Condition (AC) in which additional monitoring and accountability systems that Philani routinely uses are implemented or 2) a Control Condition (CC), of initial Philani training, but ongoing supervision and monitoring consistent with local government practices.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Accountable Condition
  • Behavioral: Control Condition
Phase 2/Phase 3

Detailed Description

Each dollar invested in maternal, child health (MCH) yields a nine-fold benefit. Home visiting has been repeatedly demonstrated efficacious in improving MCH outcomes, including when delivered by CHW in low and middle income countries (LMIC). However, when home visiting programs are scaled, they are not effective. Africa has particular challenges with broad implementation of effective interventions often associated with the poorly trained and poorly monitored health personnel, in this case, CHW who are perinatal home visitors.

The investigators have shown that with training, supervision, and accountability, CHW home visits are effective in a successful randomized controlled trial (RCT) conducted in peri-urban townships in Cape Town, South Africa. CHW were trained to address HIV, alcohol, and malnutrition among all pregnant women in a neighborhood - to avoid stigma and to address multiple challenges concurrently. The visits significantly improved maternal and child outcomes over three years. Based on these results, the Philani Intervention Model served as one model for re-engineering primary health care for 65,000 CHW in South Africa. The Mthatha Provincial Government has agreed for the Philani Program to train, monitor, and supervise their already-hired CHW. This RCT will evaluate whether routinely implementing training and monitoring CHW behavior and MCH outcomes with mobile phones, and providing data-informed supervision, will result in CHW becoming more effective. Stellenbosch University interviewers will independently assess outcomes of each mother at pregnancy, and of the mothers and infants within two weeks of post-birth, 6 months, 15 months, and 24 months later. The primary outcome will be maternal HIV/TB testing, linkage to care, treatment adherence and retention in medical regimens, depression, and parenting; and her child's physical growth, cognitive functioning, and behavior adjustment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
840 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
A Randomized Controlled Trial to Improve the South African Government's Community Health Workers' Capacities to Deliver Evidence-based Interventions for Optimizing HIV Outcomes and Reducing Its Comorbidities
Actual Study Start Date :
Jun 1, 2017
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Accountable Condition- 8 clinics

In the Accountable Condition, the intervention includes mothers who will receive home visits from government-funded CHW who will be trained once under Philani and receive ongoing monitoring and supervision.

Behavioral: Accountable Condition
Mothers will receive home visits by government-funded CHW who will be trained under Philani as well as receive ongoing monitoring and supervision. CHW will monitor mother's health and linkage to care; CHW will refer all mothers to local clinics for HIV, blood sugar, and pregnancy testing. CHW will also have a mobile phone to record information at each visit. CHW will log their home visits each day, rate the content and skills addressed on the mobile phone, weigh children, and report outcome achievements (e.g., receiving the child grant, immunizations, breastfeeding, and retention/ adherence to HIV care). The CHW in this arm will receive data-informed supervision. CHW will be monitored weekly with review of contact logs, recorded outcomes, and random site visits by supervising in-service training on a monthly basis. The Accountable Condition will last for two years (until the child is 24 months old).

Experimental: Control Condition- 8 clinics

The Control Condition will include mothers who receive home visits from government-funded CHW who will be trained once under Philani and receive supervision and monitoring consistent with local government practices.

Behavioral: Control Condition
Mothers will receive home visits by government-funded CHW who will be trained under Philani as well as receive supervision and monitoring consistent with local government practices. CHW will monitor mother's health and linkage to care. CHW will refer all mothers to local clinics for HIV, blood sugar, and pregnancy testing. The Control Condition will last for two years (until the child is 24 months old).

Outcome Measures

Primary Outcome Measures

  1. Number of significantly improved child and maternal outcomes [2 Years]

    Out of 10 variables, the investigators total number of outcomes that are significantly better in the Accountable Condition compared to the Control Condition. The variables are for mothers and children: For Mothers: Adhere to medical regimens Breastfeed for six months (mixed ok) No alcohol after learning that the participant was pregnant Mental health, EPDS For Children: Growth in height (<-2SD) Growth in weight (<-2SD) Number of Hospitalizations WHO developmental scale measure in normal range In normal range of CBCL In normal range on the Bayley

Secondary Outcome Measures

  1. Number of significantly improved child and maternal outcomes for HIV positive mothers [2 Years]

    Out of 9 variables, the investigators total the number of outcomes that are significantly better in the Accountable Condition compared to the Control Condition for HIV positive mothers. The variables are: ARV 6 weeks before birth NVP at birth Cipro for child TB testing AZT for child PCR testing at 6 weeks Get the results of PCR testing One feeding method for 6 months Breastfeed solely for 6 months.

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Mothers living in the catchment area

  • Mothers not identified as psychotic or delusional based on the interviewer's judgment

  • Mothers able to provide informed consent

Exclusion Criteria:
  • Inability to give informed consent

  • Inability to converse with the interviewer or the CHW

  • Death of the mother or infant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stellenbosch University Stellenbosch South Africa
2 Zithulele Hospital Zithulele South Africa

Sponsors and Collaborators

  • University of California, Los Angeles
  • National Institute of Mental Health (NIMH)
  • University of Stellenbosch

Investigators

  • Principal Investigator: Mary Jane Rotheram-Borus, Study Principal Investigator Department of Psychiatry & Biobehavioral Sciences, Semel Institute, UCLA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mary Jane Rotheram-Borus, Principal Investigator, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT02957799
Other Study ID Numbers:
  • R01MH111391
  • R01MH111391
First Posted:
Nov 8, 2016
Last Update Posted:
Oct 14, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mary Jane Rotheram-Borus, Principal Investigator, University of California, Los Angeles
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2021